Semaglutide helps reduce risk of heart attack, stroke in people without diabetes, study finds - ABC News

Semaglutide is the main ingredient in Wegovy and Ozempic. A recent study found it may help reduce the risk of heart attack and stroke in people without diabetes.
Semaglutide is the main ingredient in medications including Wegovy and Ozempic.
ABC News’ Dr. Jennifer Ashton explains a new study in the New England Journal of Medicine that shows a reduction in heart attacks, strokes and death in overweight or obese participants who took semaglutide.

Semaglutide helps reduce risk of heart attack, stroke in people without diabetes, study finds - ABC News

Weight-loss drug Wegovy cuts heart attack, stroke risk by 20%, study says

Remote Health Solutions

Semaglutide helps reduce risk of heart attack, stroke in people without diabetes, study finds - ABC News

JCDD, Free Full-Text

Semaglutide Reduces Heart Attack Risk and Stroke Risk, Research Finds

Semaglutide For Weight Loss: Risks, Side Effects And More – Forbes Health

CardioNerds @AHA23: SELECT: Effects of Semaglutide on Heart Disease & Stroke in Obese Patients

Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association

Remote Health Solutions

Basic Mechanisms of Diabetic Heart Disease

FDA approves the active ingredient in Mounjaro to help people with obesity lose weight, named Zepbound - Delta Daily News

Study: Drug may reduce risk of heart attack, stroke in people without diabetes - NewsChannel 13